|
Mechanism50S subunit inhibitors [+2] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date25 Jun 1958 |
100 Clinical Results associated with 50S subunit x PBP3 x GR
100 Translational Medicine associated with 50S subunit x PBP3 x GR
0 Patents (Medical) associated with 50S subunit x PBP3 x GR